Treace Capex To Depreciation vs Price To Sales Ratio Analysis

TMCI Stock

USD 10.08 0.26 2.65%

Treace Medical financial indicator trend analysis is much more than just breaking down Treace Medical Concepts prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Treace Medical Concepts is a good investment. Please check the relationship between Treace Medical Capex To Depreciation and its Price To Sales Ratio accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Capex To Depreciation vs Price To Sales Ratio

Capex To Depreciation vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Treace Medical Concepts Capex To Depreciation account and Price To Sales Ratio. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Treace Medical's Capex To Depreciation and Price To Sales Ratio is -0.56. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Treace Medical Concepts, assuming nothing else is changed. The correlation between historical values of Treace Medical's Capex To Depreciation and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Treace Medical Concepts are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Capex To Depreciation i.e., Treace Medical's Capex To Depreciation and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

-0.56

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Treace Medical Concepts stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Treace Medical sales, a figure that is much harder to manipulate than other Treace Medical Concepts multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Most indicators from Treace Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Treace Medical Concepts current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

As of now, Treace Medical's Selling General Administrative is increasing as compared to previous years. The Treace Medical's current Enterprise Value is estimated to increase to about 1.3 B, while Issuance Of Capital Stock is projected to decrease to under 71 M.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	4.7M	5.4M	6.2M	6.5M
Interest Income	910K	5.4M	6.2M	6.5M

Depreciation And Amortization Interest Income

Treace Medical fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets
Total Assets		0.88	0.99	0.99	0.99	0.81	0.96	0.59	-0.97	0.99	0.16	0.97	0.62	0.9	0.91	0.91	0.89	0.92	0.88	0.99	0.99	1.0	0.9	1.0	0.97	0.92
Short Long Term Debt Total	0.88		0.89	0.9	0.84	0.78	0.92	0.67	-0.94	0.92	0.02	0.87	0.73	1.0	0.89	0.98	0.96	0.89	1.0	0.89	0.83	0.87	1.0	0.87	0.9	0.93
Other Current Liab	0.99	0.89		1.0	0.98	0.75	0.98	0.67	-0.98	1.0	0.06	0.99	0.69	0.9	0.87	0.91	0.87	0.92	0.89	1.0	0.97	0.99	0.9	0.99	0.99	0.9
Total Current Liabilities	0.99	0.9	1.0		0.97	0.75	0.98	0.69	-0.98	1.0	0.05	0.99	0.71	0.91	0.87	0.91	0.88	0.92	0.9	1.0	0.96	0.99	0.91	0.98	0.99	0.9
Total Stockholder Equity	0.99	0.84	0.98	0.97		0.84	0.92	0.5	-0.95	0.96	0.25	0.94	0.52	0.85	0.92	0.88	0.88	0.91	0.84	0.96	1.0	0.99	0.86	1.0	0.93	0.92
Net Tangible Assets	0.81	0.78	0.75	0.75	0.84		0.7	0.11	-0.77	0.76	0.62	0.65	0.19	0.8	0.95	0.81	0.91	0.73	0.78	0.72	0.85	0.8	0.8	0.84	0.68	0.91
Property Plant And Equipment Net	0.96	0.92	0.98	0.98	0.92	0.7		0.77	-0.98	0.99	-0.07	0.98	0.8	0.92	0.83	0.91	0.87	0.9	0.92	0.99	0.91	0.96	0.92	0.95	1.0	0.86
Net Debt	0.59	0.67	0.67	0.69	0.5	0.11	0.77		-0.69	0.69	-0.68	0.76	0.99	0.64	0.34	0.61	0.48	0.62	0.67	0.71	0.46	0.6	0.65	0.54	0.77	0.44
Retained Earnings	-0.97	-0.94	-0.98	-0.98	-0.95	-0.77	-0.98	-0.69		-0.98	-0.03	-0.97	-0.72	-0.94	-0.9	-0.95	-0.91	-0.9	-0.94	-0.98	-0.94	-0.97	-0.95	-0.96	-0.98	-0.92
Accounts Payable	0.99	0.92	1.0	1.0	0.96	0.76	0.99	0.69	-0.98		0.05	0.98	0.72	0.92	0.87	0.92	0.89	0.91	0.92	1.0	0.95	0.99	0.92	0.98	0.99	0.9
Cash	0.16	0.02	0.06	0.05	0.25	0.62	-0.07	-0.68	-0.03	0.05		-0.09	-0.63	0.08	0.4	0.09	0.25	0.04	0.03	0.01	0.3	0.15	0.05	0.22	-0.08	0.3
Non Current Assets Total	0.97	0.87	0.99	0.99	0.94	0.65	0.98	0.76	-0.97	0.98	-0.09		0.77	0.87	0.81	0.89	0.83	0.92	0.87	0.99	0.92	0.97	0.88	0.95	1.0	0.85
Non Currrent Assets Other	0.62	0.73	0.69	0.71	0.52	0.19	0.8	0.99	-0.72	0.72	-0.63	0.77		0.7	0.4	0.66	0.54	0.62	0.73	0.73	0.48	0.61	0.7	0.57	0.78	0.49
Long Term Debt	0.9	1.0	0.9	0.91	0.85	0.8	0.92	0.64	-0.94	0.92	0.08	0.87	0.7		0.91	0.98	0.97	0.89	1.0	0.9	0.85	0.88	0.99	0.89	0.9	0.94
Cash And Short Term Investments	0.91	0.89	0.87	0.87	0.92	0.95	0.83	0.34	-0.9	0.87	0.4	0.81	0.4	0.91		0.94	0.97	0.89	0.9	0.85	0.93	0.9	0.92	0.92	0.82	0.99
Net Receivables	0.91	0.98	0.91	0.91	0.88	0.81	0.91	0.61	-0.95	0.92	0.09	0.89	0.66	0.98	0.94		0.97	0.94	0.98	0.91	0.88	0.9	1.0	0.9	0.9	0.97
Common Stock Total Equity	0.89	0.96	0.87	0.88	0.88	0.91	0.87	0.48	-0.91	0.89	0.25	0.83	0.54	0.97	0.97	0.97		0.89	0.96	0.86	0.87	0.88	0.97	0.89	0.85	0.98
Common Stock Shares Outstanding	0.92	0.89	0.92	0.92	0.91	0.73	0.9	0.62	-0.9	0.91	0.04	0.92	0.62	0.89	0.89	0.94	0.89		0.89	0.92	0.9	0.92	0.92	0.91	0.91	0.92
Non Current Liabilities Total	0.88	1.0	0.89	0.9	0.84	0.78	0.92	0.67	-0.94	0.92	0.03	0.87	0.73	1.0	0.9	0.98	0.96	0.89		0.89	0.83	0.87	1.0	0.87	0.9	0.94
Inventory	0.99	0.89	1.0	1.0	0.96	0.72	0.99	0.71	-0.98	1.0	0.01	0.99	0.73	0.9	0.85	0.91	0.86	0.92	0.89		0.95	0.99	0.9	0.98	0.99	0.88
Other Current Assets	0.99	0.83	0.97	0.96	1.0	0.85	0.91	0.46	-0.94	0.95	0.3	0.92	0.48	0.85	0.93	0.88	0.87	0.9	0.83	0.95		0.99	0.85	0.99	0.92	0.92
Other Stockholder Equity	1.0	0.87	0.99	0.99	0.99	0.8	0.96	0.6	-0.97	0.99	0.15	0.97	0.61	0.88	0.9	0.9	0.88	0.92	0.87	0.99	0.99		0.89	1.0	0.97	0.91
Total Liab	0.9	1.0	0.9	0.91	0.86	0.8	0.92	0.65	-0.95	0.92	0.05	0.88	0.7	0.99	0.92	1.0	0.97	0.92	1.0	0.9	0.85	0.89		0.89	0.9	0.96
Net Invested Capital	1.0	0.87	0.99	0.98	1.0	0.84	0.95	0.54	-0.96	0.98	0.22	0.95	0.57	0.89	0.92	0.9	0.89	0.91	0.87	0.98	0.99	1.0	0.89		0.95	0.93
Property Plant And Equipment Gross	0.97	0.9	0.99	0.99	0.93	0.68	1.0	0.77	-0.98	0.99	-0.08	1.0	0.78	0.9	0.82	0.9	0.85	0.91	0.9	0.99	0.92	0.97	0.9	0.95		0.86
Total Current Assets	0.92	0.93	0.9	0.9	0.92	0.91	0.86	0.44	-0.92	0.9	0.3	0.85	0.49	0.94	0.99	0.97	0.98	0.92	0.94	0.88	0.92	0.91	0.96	0.93	0.86

Click cells to compare fundamentals

Treace Medical Account Relationship Matchups

Treace Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	41.8M	140.8M	159.0M	251.9M	289.7M	304.2M
Short Long Term Debt Total	31.0M	29.4M	68.6M	70.3M	80.8M	48.1M
Other Current Liab	7.5M	14.2M	20.9M	31.8M	36.6M	38.4M
Total Current Liabilities	11.6M	18.2M	30.2M	45.0M	51.8M	54.4M
Total Stockholder Equity	776K	93.1M	60.5M	137.9M	158.6M	166.6M
Property Plant And Equipment Net	829K	2.8M	25.5M	31.6M	36.3M	38.1M
Net Debt	12.9M	(76.5M)	49.1M	57.3M	65.9M	69.2M
Retained Earnings	(21.4M)	(41.9M)	(84.7M)	(134.2M)	(120.8M)	(114.8M)
Accounts Payable	2.3M	4.1M	8.7M	11.8M	13.6M	14.3M
Cash	18.1M	105.8M	19.5M	13.0M	14.9M	14.2M
Non Current Assets Total	829K	2.8M	25.6M	53.5M	61.6M	64.7M
Long Term Debt	29.2M	29.4M	52.7M	53.0M	61.0M	40.4M
Cash And Short Term Investments	18.1M	105.8M	81.3M	123.2M	141.7M	74.9M
Net Receivables	14.5M	18.6M	29.2M	38.1M	43.8M	24.4M
Liabilities And Stockholders Equity	41.8M	140.8M	159.0M	251.9M	289.7M	304.2M
Non Current Liabilities Total	29.4M	29.5M	68.3M	68.9M	79.3M	47.4M
Inventory	7.8M	10.6M	19.3M	29.2M	33.6M	35.3M
Other Current Assets	593K	6.0M	3.6M	7.9M	9.0M	9.5M
Other Stockholder Equity	14.2M	134.9M	145.2M	272.0M	312.8M	328.4M
Total Liab	41.0M	47.7M	98.5M	114.0M	131.1M	72.1M
Net Invested Capital	23.8M	122.4M	113.2M	190.9M	219.6M	230.6M
Property Plant And Equipment Gross	829K	2.8M	25.5M	40.3M	46.4M	48.7M
Total Current Assets	41.0M	138.0M	133.4M	198.4M	228.1M	118.6M
Net Working Capital	29.4M	119.8M	103.2M	153.3M	176.3M	93.9M

Currently Active Assets on Macroaxis

CSX	CSX Corporation
ETON	Eton Pharmaceuticals
ALLT	Allot Communications
DIA	SPDR Dow Jones
SPY	SPDR SP 500

When determining whether Treace Medical Concepts offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Treace Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Treace Medical Concepts Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Treace Medical Concepts Stock:

How To Invest In Treace

Details

Is Treace Stock a good investment?

Details

What is Treace Medical's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Treace Medical Concepts. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Treace Medical. If investors know Treace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Treace Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.99)

Revenue Per Share

3.274

Quarterly Revenue Growth

0.106

Return On Assets

(0.17)

Return On Equity

(0.51)

The market value of Treace Medical Concepts is measured differently than its book value, which is the value of Treace that is recorded on the company's balance sheet. Investors also form their own opinion of Treace Medical's value that differs from its market value or its book value, called intrinsic value, which is Treace Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Treace Medical's market value can be influenced by many factors that don't directly affect Treace Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Treace Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Treace Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Treace Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Treace Capex To Depreciation vs Price To Sales Ratio Analysis

Capex To Depreciation vs Price To Sales Ratio

Capex To Depreciation vs Price To Sales Ratio Correlation Analysis

Correlation Coefficient

Capex To Depreciation

Price To Sales Ratio

Treace Medical fundamental ratios Correlations

Treace Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Treace Medical fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Stockholder Equity	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Long Term Debt	+ 1.0	Short Long Term Debt Total
Non Current Liabilities Total	+ 1.0	Short Long Term Debt Total
Total Liab	+ 1.0	Short Long Term Debt Total
Total Current Liabilities	+ 1.0	Other Current Liab

Property Plant And Equipment Gross	- 0.98	Retained Earnings
Inventory	- 0.98	Retained Earnings
Accounts Payable	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Property Plant And Equipment Net
Retained Earnings	- 0.98	Total Current Liabilities
Retained Earnings	- 0.98	Other Current Liab